Skip to content

The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases

Investigation of the Effectiveness of Immediate Smoking Cessation Interventions During Routine Outpatient Service in Current Smoker Chronic Airway Disease Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05764343
Enrollment
397
Registered
2023-03-10
Start date
2022-11-15
Completion date
2023-09-15
Last updated
2023-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma COPD, Bronchiectasis Adult, Tobacco Cessation

Keywords

tobacco cessation, asthma, COPD, bronchiectasis, immediate cessation support

Brief summary

Smoking cessation support is provided by smoking cessation outpatient clinics in our country. Smokers with chronic airway diseases can also apply to these services by making an appointment from quit lines. Quit rates of that group patients were found to be similar to the general population. In novel smoking cessation support approaches immediate cessation support is reported to be more effective than routine practice. The sample in these studies consists of individuals who applied for lung health screening programmes. There is no study in the literature examining the effect of this immediate support on patients with chronic airway diseases' quit success. Our aim with this study is to examine impact of immediate cessation support by getting an appointment to the same cessation clinic instantly on our sample's cessation success.

Detailed description

Patients who are current smokers (who have smoked at least 100 cigarettes in their lifetime and still smoke daily or some days) will be randomized in a 1:1 ratio to the two arms in sequential order of presentation, after they have been identified and given written informed consent about the study. Demographic and clinical features will be filled. A brief smoking cessation intervention will be applied to one group and they will be recommended to apply to smoking cessation outpatient clinics by obtaining appointment from quit lines, as the way of current routine practice. Those randomized to the other group will have an immediate appointment at the smoking cessation outpatient clinic in addition to the brief smoking cessation intervention. Both patient groups will be called after 1 week by phone to inquire about their smoking cessation status and their application to smoking cessation outpatient clinics. Both groups will be called again in the 3rd month and their smoking cessation status, their application to smoking cessation outpatient clinics, and the duration/status of using pharmacological smoking cessation treatments will be questioned.

Interventions

OTHERImmediate smoking cessation support

Smoker patients with chronic airway diseases (asthma and/or COPD and/or bronchiectasis) will be evaluated for the inclusion criteria. Afterwards they will be randomized as routine support arm (as the current procedure of the care) and immediate support arm (intensive brief cessation advices following by the immediate arrangement of the appointment from the same clinic's smoking cessation service). Both arms will be followed remotely at first week and third months of the randomization regarding their quit status as well as their use of evidence based cessation treatments.

Sponsors

Turkish Thoracic Society
CollaboratorOTHER
Recep Tayyip Erdogan University Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Being age 18 years and over, 2. Having diagnoses of asthma and/or COPD and/or bronchiectasis for at least 6 months, 3. Applying to the chest diseases outpatient clinics, 4. Being an current smoker, 5. Those who agree to participate in the study, 6. Patients who can be reached by phone calls at 1 week and 3 months after randomization.

Exclusion criteria

1. Those with active psychiatric disorders 2. Patients with impaired cognitive functions.

Design outcomes

Primary

MeasureTime frameDescription
Quit rate of both study armsAt third month of randomizationTo compare the quit rate at third month of randomization in the both arms: intensive support arm compared to routine support arm. A quitter will be considered who have never smoked since the target quit day.

Secondary

MeasureTime frameDescription
Smoking cessation outpatient clinic application rate of both study armsAt third monthThe admission status to smoking cessation outpatient clinics of both arms will be evaluated: admitted at least once or never admitted.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026